Home › Epizyme: The Ugly Duckling Of The 2014 Biotech Rally?
 

Keywords :   


Epizyme: The Ugly Duckling Of The 2014 Biotech Rally?

2015-01-02 17:10:52| Biotech - Topix.net

When I analyzed Epizyme a year ago , I argued that Epizyme represents a promising early biotech company developing novel small molecule inhibitors targeting specific epigenome modifying mutations. After a precipitous drop of the stock price in November, the stock was a no-brainer for me.

Tags: rally ugly biotech duckling

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Tropical Depression Fourteen Graphics
05.10Tropical Depression Fourteen Forecast Discussion Number 1
05.10Tropical Depression Fourteen Wind Speed Probabilities Number 1
05.10Tropical Depression Fourteen Public Advisory Number 1
05.10Summary for Tropical Depression Fourteen (AT4/AL142024)
05.10Tropical Depression Fourteen Forecast Advisory Number 1
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 25
More »